Free Trial

Amarin (AMRN) Stock Forecast & Price Target

$0.73
-0.03 (-3.95%)
(As of 06/18/2024 ET)

Amarin - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$1.08
48.38% Upside
High Forecast$1.25
Average Forecast$1.08
Low Forecast$1.00
TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus Rating
Reduce
Reduce
Reduce
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$1.08$1.08$1.08$2.50
Forecasted Upside48.38% Upside5.99% Upside5.99% Upside105.76% Upside
Get Amarin Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter.

AMRN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AMRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Amarin Stock vs. The Competition

TypeAmarinMedical CompaniesS&P 500
Consensus Rating Score
1.75
2.70
2.50
Consensus RatingReduceModerate BuyHold
Predicted Upside48.38% Upside1,068.19% Upside11.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
11/20/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderweight
10/25/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$3.00 ➝ $1.00+31.53%
7/20/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell$1.50 ➝ $1.00-7.41%
7/19/2023Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$2.00 ➝ $1.25-12.59%
10/19/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ruiz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetMarket Perform$3.00 ➝ $2.00+70.94%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:01 AM ET.

AMRN Forecast - Frequently Asked Questions

What is Amarin's stock forecast and purchase recommendation?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Amarin is $1.08, with a high forecast of $1.25 and a low forecast of $1.00. The consensus rating for Amarin stock is Reduce based on the current 2 sell ratings, 1 hold rating and 1 buy rating for AMRN. Learn more on AMRN's analyst rating history.

Do Wall Street analysts like Amarin more than its competitors?

Analysts like Amarin less than other "medical" companies. The consensus rating for Amarin is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AMRN compares to other companies.

Does Amarin's stock price have much upside?

According to analysts, Amarin's stock has a predicted upside of 5.99% based on their 12-month stock forecasts.

What analysts cover Amarin?

Amarin has been rated by research analysts at Cantor Fitzgerald in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:AMRN) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners